Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Interest & Investment Income data on record, last reported at $7.0 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 623.2% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $17.1 million, changed N/A, while the annual FY2025 figure was $16.5 million, 131.63% up from the prior year.
  • Interest & Investment Income reached $7.0 million in Q4 2025 per CAI's latest filing, down from $7.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.4 million in Q3 2025 and bottomed at $970000.0 in Q4 2024.